scabies
SCABIES
Scabies is a contagious disease caused by the mite Sarcoptes scabiei var hominis.
The affected individual usually complains of having a highly pruritic rash that occurs at night.
It occurs more often in children <15 years of age, sexually active young adults, the immunocompromised and in persons living in crowded living conditions (eg nursing homes, military barracks).
Transmission is typically by direct skin contact with an infected person and in adults, sexual transmission is common.

Scabies Management

Prevention

Crusted Scabies

Control of Disease Dissemination

  • In the case of crusted scabies there is an increased risk of transmission to contact persons
    • Strict isolation of the patient should be observed until cure is achieved
    • Avoidance of direct skin contact: Use of gloves and gowns by hospital staff
    • Careful washing of the patient’s clothes, linens and towels, etc
  • Both low and high risk patient contacts should be treated
    • High-risk contacts: Persons with protracted or frequent skin contact (eg via the hands) with the infected individual should be treated regardless of the presence of symptoms
    • Low risk contacts: Persons with indirect contact (eg via bedding) to the infected individual only need treatment in the case of crusted scabies
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
16 Jan 2021
Diagnosis of heart diseases has abruptly and significantly decreased across the globe due to the coronavirus disease 2019 (COVID-19) pandemic, especially affecting poorer countries, reveals a study.
Roshini Claire Anthony, 01 Dec 2020

An evidence-based, multifaceted intervention aimed at reducing haemodialysis catheter-related bloodstream infections (HD-CRBSIs) failed to improve this outcome, results of the REDUCCTION* trial showed.

Pearl Toh, Yesterday
While it is well known that COVID-19 illness is associated with coagulopathy, the optimal anticoagulation strategy remains elusive, and two studies presented at the ASH 2020 Congress further add to the growing debate on the appropriate anticoagulant dose for hospitalized patients with COVID-19.